IE36337B1 - Pharmaceutical compositions - Google Patents

Pharmaceutical compositions

Info

Publication number
IE36337B1
IE36337B1 IE564/72A IE56472A IE36337B1 IE 36337 B1 IE36337 B1 IE 36337B1 IE 564/72 A IE564/72 A IE 564/72A IE 56472 A IE56472 A IE 56472A IE 36337 B1 IE36337 B1 IE 36337B1
Authority
IE
Ireland
Prior art keywords
sodium
pharmaceutically acceptable
chloride
salt
compositions
Prior art date
Application number
IE564/72A
Other languages
English (en)
Other versions
IE36337L (en
Original Assignee
Fisons Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26250625&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IE36337(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Fisons Ltd filed Critical Fisons Ltd
Publication of IE36337L publication Critical patent/IE36337L/xx
Publication of IE36337B1 publication Critical patent/IE36337B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IE564/72A 1971-05-12 1972-04-28 Pharmaceutical compositions IE36337B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1452971 1971-05-12
GB5716971A GB1399834A (en) 1971-05-12 1971-12-09 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
IE36337L IE36337L (en) 1972-11-12
IE36337B1 true IE36337B1 (en) 1976-10-13

Family

ID=26250625

Family Applications (1)

Application Number Title Priority Date Filing Date
IE564/72A IE36337B1 (en) 1971-05-12 1972-04-28 Pharmaceutical compositions

Country Status (15)

Country Link
JP (1) JPS5425082B1 (xx)
AU (1) AU465305B2 (xx)
BE (1) BE782981A (xx)
CA (1) CA1000201A (xx)
CY (1) CY955A (xx)
DE (2) DE2223237C2 (xx)
DK (1) DK131324B (xx)
FR (1) FR2139872B1 (xx)
GB (1) GB1399834A (xx)
HK (1) HK69276A (xx)
IE (1) IE36337B1 (xx)
IL (1) IL39286A (xx)
MY (1) MY7700080A (xx)
NL (1) NL177386B (xx)
SE (1) SE396011B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2230358A2 (en) * 1973-05-25 1974-12-20 Fisons Ltd Cromoglycate contg. solns. - contg. a second therapeutically active cpd. e.g. an antihistamine
DE2634908A1 (de) * 1974-11-09 1977-04-14 Fisons Ltd Mittel zur behandlung chronischer haut- oder augenerkrankungen
DE3700379A1 (de) * 1987-01-08 1988-07-21 Mann Gerhard Chem Pharm Fab Konservierte augentropfen mit einem gehalt an cromoglicinsaeure
AT410894B (de) * 1988-03-22 2003-08-25 Fisons Plc Verwendung einer wässerigen lösung von natriumcromoglycat und chlorbutol
GB8819490D0 (en) * 1988-08-16 1988-09-21 Fisons Plc Pharmaceutical devices
GB2216794B (en) * 1988-03-22 1991-11-20 Fisons Plc Pharmaceuticals compositions
FR2649890A1 (fr) * 1988-03-22 1991-01-25 Fisons Plc Compositions pharmaceutiques
WO1997024142A1 (fr) * 1995-12-27 1997-07-10 Showa Yakuhin Kako Co., Ltd. Composition aqueuse contenant de l'acide cromoglycique
DE19614823A1 (de) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmische Zusammensetzung mit verlängerter Verweilzeit am Auge
EP0938896A1 (en) * 1998-01-15 1999-09-01 Novartis AG Autoclavable pharmaceutical compositions containing a chelating agent
JP5785353B2 (ja) * 2004-02-27 2015-09-30 大正製薬株式会社 眼科用剤
JP5992293B2 (ja) * 2012-10-31 2016-09-14 大正製薬株式会社 眼科用剤
PL426472A1 (pl) * 2018-07-27 2020-02-10 Kalbarczyk Grzegorz Arkona Laboratorium Farmakologii Stomatologicznej Zastosowanie medyczne bromku domifenu oraz kompozycja do leczenia stanów zapalnych w obrębie jamy ustnej

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1144905A (en) * 1965-03-25 1969-03-12 Fisons Pharmaceuticals Ltd Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
GB1190194A (en) * 1966-07-05 1970-04-29 Fisons Pharmaceuticals Ltd Bis-Phenoxy Compounds and Chromanone and Chromone Derivatives

Also Published As

Publication number Publication date
IL39286A0 (en) 1972-06-28
NL7206251A (xx) 1972-11-14
IL39286A (en) 1975-02-10
DK131324B (da) 1975-06-30
DK131324C (xx) 1975-11-24
FR2139872A1 (xx) 1973-01-12
DE2266025A1 (xx) 1985-03-07
FR2139872B1 (xx) 1975-10-31
BE782981A (fr) 1972-11-03
CY955A (en) 1978-12-22
NL177386B (nl) 1985-04-16
CA1000201A (en) 1976-11-23
IE36337L (en) 1972-11-12
MY7700080A (en) 1977-12-31
AU465305B2 (en) 1975-09-25
SE396011B (sv) 1977-09-05
AU4208072A (en) 1973-11-15
HK69276A (en) 1976-11-12
DE2223237C2 (de) 1985-01-17
DE2223237A1 (de) 1972-12-14
GB1399834A (en) 1975-07-02
JPS5425082B1 (xx) 1979-08-25

Similar Documents

Publication Publication Date Title
KR100211479B1 (ko) 3-[2-(디메틸아미노)에틸]-n-메틸-1h-인돌-5-메탄술폰아미드의 비강 투여 제제
IE36337B1 (en) Pharmaceutical compositions
US4201706A (en) Treatment of corneal edema
NO156690C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indanderivater.
EP0275457B1 (en) Solution containing lysozyme hydrochloride and dipotassium glycyrrhizinate
US3232833A (en) Heparin containing compositions
US4197301A (en) Topical ophthalmic use of Prazosin
WO2002000166A3 (en) New compounds useful as antibacterial agents
JPH0637388B2 (ja) 水性液剤
US4415564A (en) Pharmaceutical preparation for treating glaucoma and ocular hypertension
US2550398A (en) Antibiotic compositions
JPH0780760B2 (ja) 安定化されたフエニレフリン系液剤
US3991206A (en) Alleviation of eye inflammation by topical application of p-biphenylacetic acid
ES8106003A1 (es) Procedimiento para la obtencion de acido fosfonohidroxiace- tico
JPH0717863A (ja) プラノプロフェン点眼液
JPH1029937A (ja) メフェナム酸水溶液製剤
US3920824A (en) Stable ophthalmic formulation
JPH05505405A (ja) アメトカインを含有する医薬組成物
JPH05221873A (ja) 鼻および目に局所使用するためのブラジキニン拮抗剤含有薬学的組成物
US4666926A (en) Transdermal formulations
JPH0132805B2 (xx)
US4377583A (en) N-Methyl-D-glucamine salt of with 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-carboxylic acid
US4322425A (en) Compositions for treating glaucoma
NO833529L (no) Fremgangsmaate for fremstilling av terapeutisk aktive alfa-aryl-alfa-pyridylalkansyrederivater
SE451070B (sv) Anvendning av ett karbostyrilderivat for framstellning av ett lekemedel for behandling av glaukom